High-resolution atomic force microscopy of soluble Aβ42 oligomers

Journal of Molecular Biology

Volumn 358, Issue 1, 2006, Pages 106-119

  Mastrangelo, Iris A ^a,b   Ahmed, Mahiuddin ^b   Sato, Takeshi ^b   Liu, Wei ^b   Wang, Chengpu ^a   Hough, Paul ^a,b   Smith, Steven O ^b  

^a LifeAFM Inc   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Amyloid beta; Atomic force microscopy; Protofibrils; Soluble oligomer

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DIMER; MONOMER; OLIGOMER; PROTEIN ABETA42; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; FIBER; INCUBATION TIME; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 33645108790     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.01.042     Document Type: Article

References (72)

1. D.J. Selkoe Presenilin, Notch, and the genesis and treatment of Alzheimer's disease Proc. Natl Acad. Sci. USA 98 2001 11039 11041
2. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
3. D.A. Kirschner, C. Abraham, and D.J. Selkoe X-ray-diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer-disease indicates cross-β conformation Proc. Natl Acad. Sci. USA 83 1986 503 507
4. D.M. Hartley, D.M. Walsh, C.P.P. Ye, T. Diehl, S. Vasquez, and P.M. Vassilev Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons J. Neurosci. 19 1999 8876 8884
5. 1-42 are potent central nervous system neurotoxins Proc. Natl Acad. Sci. USA 95 1998 6448 6453
6. Y.M. Kuo, M.R. Emmerling, C. VigoPelfrey, T.C. Kasunic, J.B. Kirkpatrick, and G.H. Murdoch Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains J. Biol. Chem. 271 1996 4077 4081
7. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, and K. Beyreuther Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 46 1999 860 866
8. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, and L. Sue Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease Am. J. Pathol. 155 1999 853 862
9. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, and M.S. Wolfe Naturally secreted oligomers of amyloid-β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
10. K.N. Dahlgren, A.M. Manelli, W.B. Stine Jr, L.K. Baker, G.A. Krafft, and M.J. LaDu Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability J. Biol. Chem. 277 2002 32046 32053
11. D.M. Walsh, D.M. Hartley, Y. Kusumoto, Y. Fezoui, M.M. Condron, and A. Lomakin Amyloid β-protein fibrillogenesis-structure and biological activity of protofibrillar intermediates J. Biol. Chem. 274 1999 25945 25952
12. D.M. Walsh, A. Lomakin, G.B. Benedek, M.M. Condron, and D.B. Teplow Amyloid β-protein fibrillogenesis - detection of a protofibrillar intermediate J. Biol. Chem. 272 1997 22364 22372
13. C. Hilbich, B. Kisters-Woike, J. Reed, C.L. Masters, and K. Beyreuther Aggregation and secondary structure of synthetic amyloid-β A4 peptides of Alzheimer's disease J. Mol. Biol. 218 1991 149 163
14. W. Garzon-Rodriguez, M. Sepulveda-Becerra, S. Milton, and C.G. Glabe Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations J. Biol. Chem. 272 1997 21037 21044
15. C. Soto, E.M. Castano, R.A. Kumar, R.C. Beavis, and B. Frangione Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure Neurosci. Letters 200 1995 105 108
16. T.H.J. Huang, D.S. Yang, N.P. Plaskos, S. Go, C.M. Yip, P.E. Fraser, and A. Chakrabartty Structural studies of soluble oligomers of the Alzheimer β-amyloid peptide J. Mol. Biol. 297 2000 73 87
17. L.K. Simmons, P.C. May, K.J. Tomaselli, R.E. Rydel, K.S. Fuson, and E.F. Brigham Secondary structure of amyloid β-peptide correlates with neurotoxic activity in vitro Mol. Pharmacol. 45 1994 373 379
18. E. Terzi, G. Hölzemann, and J. Seelig Interaction of Alzheimer β-amyloid peptide(1-40) with lipid membranes Biochemistry 36 1997 14845 14852
19. K. Matsuzaki, and C. Horikiri Interactions of amyloid-β peptide (1-40) with ganglioside-containing membranes Biochemistry 38 1999 4137 4142
20. S.R. Ji, Y. Wu, and S.F. Sui Cholesterol is an important factor affecting the membrane insertion of β-amyloid peptide (Aβ 1-40), which may potentially inhibit the fibril formation J. Biol. Chem. 277 2002 6273 6279
21. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
22. H.A. Lashuel, D.M. Hartley, B.M. Petre, J.S. Wall, M.N. Simon, T. Walz, and P.T. Lansbury Mixtures of wild-type and a pathogenic (E22G) form of Aβ 40 in vitro accumulate protofibrils, including amyloid pores J. Mol. Biol. 332 2003 795 808
23. B. Soreghan, J. Kosmoski, and C. Glabe Surfactant properties of Alzheimers Aβ peptides and the mechanism of amyloid aggregation J. Biol. Chem. 269 1994 28551 28554
24. Y.S. Gong, L. Chang, K.L. Viola, P.N. Lacor, M.P. Lambert, and C.E. Finch Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss Proc. Natl Acad. Sci. USA 100 2003 10417 10422
25. M. Buttini, E. Masliah, R. Barbour, H. Grajeda, R. Motter, and K. Johnson-Wood β-Amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease J. Neurosci. 25 2005 9096 9101
26. W.E. Müller, S. Koch, A. Eckert, H. Hartmann, and K. Scheuer β Amyloid peptide decreases membrane fluidity Brain Res. 674 1995 133 136
27. R.P. Mason, J.D. Estermyer, J.F. Kelly, and P.E. Mason Alzheimer's disease amyloid β peptide 25-35 is localized in the membrane hydrocarbon core: X-ray diffraction analysis Biochem. Biophys. Res. Commun. 222 1996 78 82
28. N.A. Avdulov, S.V. Chochina, U. Igbavboa, C.S. Warden, A.V. Vassiliev, and W.G. Wood Lipid binding to amyloid β-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids J. Neurochem. 69 1997 1746 1752
29. K.Y.C. Lee, A. Muresan, and C. Ege Interactions of Alzheimer's amyloid-β peptides with lipid membranes Biophys. J. 80 2001 23A
30. A. Quist, I. Doudevski, H. Lin, R. Azimova, D. Ng, and B. Frangione Amyloid ion channels: a common structural link for protein-misfolding disease Proc. Natl Acad. Sci. USA 102 2005 10427 10432
31. N. Arispe Architecture of the Alzheimer's AβP ion channel pore J. Membr. Biol. 197 2004 33 48
32. N. Arispe, H.B. Pollard, and E. Rojas Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [A(P-(1-40)] in bilayer membranes Proc. Natl Acad. Sci. USA 90 1993 10573 10577
33. N. Arispe, E. Rojas, and H.B. Pollard Alzheimer disease amyloid (protein forms calcium channels in bilayer-membranes: blockade by tromethamine and aluminum Proc. Natl Acad. Sci. USA 90 1993 567 571
34. R. Kayed, Y. Sokolov, B. Edmonds, T.M. McIntire, S.C. Milton, J.E. Hall, and C.G. Glabe Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases J. Biol. Chem. 279 2004 46363 46366
35. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, and N. Wang ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452
36. C.S. Goldsbury, S. Wirtz, S.A. Müller, S. Sunderji, P. Wicki, U. Aebi, and P. Frey Studies on the in vitro assembly of Aβ 1-40: implications for the search for Aβ fibril formation inhibitors J. Struct. Biol. 130 2000 217 231
37. 1-42 dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease J. Biol. Chem. 271 1996 20631 20635
38. Z. Wang, C. Zhou, C. Wang, L. Wan, X. Fang, and C. Bai AFM and STM study of β-amyloid aggregation on graphite Ultramicroscopy 97 2003 73 79
39. 1-42 fibrillogenesis with atomic force microscopy FASEB J. 19 2005 1344 1346
40. J. Hardy Amyloid, the presenilins and Alzheimer's disease Trends Neurosci. 20 1997 154 159
41. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, and L. Fidani Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706
42. J.D. Harper, S.S. Wong, C.M. Lieber, and P.T. Lansbury Observation of metastable Aβ amyloid protofibrils by atomic force microscopy Chem. Biol. 4 1997 119 125
43. J.D. Harper, S.S. Wong, C.M. Lieber, and P.T. Lansbury Assembly of A (amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease Biochemistry 38 1999 8972 8980
44. T. Kowalewski, and D.M. Holtzman In situ atomic force microscopy study of Alzheimer's β-amyloid peptide on different substrates: new insights into mechanism of β-sheet formation Proc. Natl Acad. Sci. USA 96 1999 3688 3693
45. M.R. Nichols, M.A. Moss, D.K. Reed, W.L. Lin, R. Mukhopadhyay, J.H. Hoh, and T.L. Rosenberry Growth of β-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy Biochemistry 41 2002 6115 6127
46. A.T. Petkova, Y. Ishii, J.J. Balbach, O.N. Antzutkin, R.D. Leapman, F. Delaglio, and R. Tycko A structural model for Alzheimer's ®-amyloid fibrils based on experimental constraints from solid state NMR Proc. Natl Acad. Sci. USA 99 2002 16742 16747
47. T. Lührs, C. Ritter, M. Adrian, D. Riek-Loher, B. Bohrmann, and H. Döbeli 3D structure of Alzheimer's amyloid-β(1-42) fibrils Proc. Natl Acad. Sci. USA 102 2005 17342 17347
48. N.D. Lazo, M.A. Grant, M.C. Condron, A.C. Rigby, and D.B. Teplow On the nucleation of amyloid β-protein monomer folding Protein Sci. 14 2005 1581 1596
49. M. Torok, S. Milton, R. Kayed, P. Wu, T. McIntire, C.G. Glabe, and R. Langen Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling J. Biol. Chem. 277 2002 40810 40815
50. I. Kheterpal, A. Williams, C. Murphy, B. Bledsoe, and R. Wetzel Structural features of the Aβ amyloid fibril elucidated by limited proteolysis Biochemistry 40 2001 11757 11767
51. A.T. Petkova, R.D. Leapman, Z.H. Guo, W.M. Yau, M.P. Mattson, and R. Tycko Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils Science 307 2005 262 265
52. C. Goldsbury, P. Frey, V. Olivieri, U. Aebi, and S.A. Müller Multiple assembly pathways underlie amyloid-β fibril polymorphisms J. Mol. Biol. 352 2005 282 298
53. H.K.L. Blackley, N. Patel, M.C. Davies, C.J. Roberts, S.J.B. Tendler, M.J. Wilkinson, and P.M. Williams Morphological development of Aβ (1-40) amyloid fibrils Expt. Neurol. 158 1999 437 443
54. H.L. Chu, and S.Y. Lin Temperature-induced conformational changes in amyloid (1-40) peptide investigated by simultaneous FT-IR microspectroscopy with thermal system Biophys. Chem. 89 2001 173 180
55. W.C. Johnson Analyzing protein circular dichroism spectra for accurate secondary structures Proteins: Struct. Funct. Genet. 35 1999 307 312
56. T. Ban, M. Hoshino, S. Takahashi, D. Hamada, K. Hasegawa, H. Naiki, and Y. Goto Direct observation of Aβ amyloid fibril growth and inhibition J. Mol. Biol. 344 2004 757 767
57. O.N. Antzutkin, R.D. Leapman, J.J. Balbach, and R. Tycko Supramolecular structural constraints on Alzheimer's β-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance Biochemistry 41 2002 15436 15450
58. J.T. Jarrett, E.P. Berger, and P.T. Lansbury The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation-implications for the pathogenesis of Alzheimer's disease Biochemistry 32 1993 4693 4697
59. K.L. Sciarretta, D.J. Gordon, A.T. Petkova, R. Tycko, and S.C. Meredith Aβ 40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid Biochemistry 44 2005 6003 6014
60. W. Liu, E. Crocker, W. Zhang, J.I. Elliott, B. Luy, and H. Li Structural role of glycine in amyloid fibrils formed from transmembrane α-helices Biochemistry 44 2005 3591 3597
61. M. Pitschke, R. Prior, M. Haupt, and D. Riesner Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy Nature Med. 4 1998 832 834
62. L.K. Tamm, and S.A. Tatulian Infrared spectroscopy of proteins and peptides in lipid bilayers Quart. Rev. Biophys. 30 1997 365 429
63. P.K. Hansma, J.P. Cleveland, M. Radmacher, D.A. Walters, P.E. Hillner, and M. Bezanilla Tapping mode atomic-force microscopy in liquids Appl. Phys. Letters 64 1994 1738 1740
64. W.H. Han, S.M. Lindsay, and T.W. Jing A magnetically driven oscillating probe microscope for operation in liquids Appl. Phys. Letters 69 1996 4111 4113
65. M. Guthold, X. Zhu, C. Rivetti, G. Yang, N.H. Thomson, and S. Kasas Direct observation of one-dimensional diffusion and transcription by Escherichia coli RNA polymerase Biophys. J. 77 1999 2284 2294
66. G. Binnig, C.F. Quate, and C. Gerber Atomic force microscope Phys. Rev. Letters 56 1986 930 933
67. D.J. Müller, A. Engel, U. Matthey, T. Meier, P. Dimroth, and K. Suda Observing membrane protein diffusion at subnanometer resolution J. Mol. Biol. 327 2003 925 930
68. E.L. Florin, V.T. Moy, and H.E. Gaub Adhesion forces between individual ligand-receptor pairs Science 264 1994 415 417
69. H.G. Hansma, and D.E. Laney DNA binding to mica correlates with cationic radius: assay by atomic force microscopy Biophys. J. 70 1996 1933 1939
70. J. Mou, D.M. Czajkowsky, Y. Zhang, and Z. Shao High-resolution atomic-force microscopy of DNA: the pitch of the double helix FEBS Letters 371 1995 279 282
71. J.H. Kindt, J.C. Sitko, L.I. Pietrasanta, E. Oroudjev, N. Becker, M.B. Viani, and H.G. Hansma Methods for biological probe microscopy in aqueous fluids Methods Cell Biol. 68 2002 213 229
72. R. Tycko Progress towards a molecular-level structural understanding of amyloid fibrils Curr. Opin. Struct. Biol. 14 2004 96 103